Search alternatives:
greater decrease » greater increase (Expand Search), greater increases (Expand Search), rate decreased (Expand Search)
large decreases » largest decreases (Expand Search), large increases (Expand Search), largest decrease (Expand Search)
larger decrease » marked decrease (Expand Search)
mean decrease » a decrease (Expand Search)
Showing 81 - 100 results of 37,370 for search '(( a ((greater decrease) OR (mean decrease)) ) OR ( i ((large decreases) OR (larger decrease)) ))', query time: 1.10s Refine Results
  1. 81
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 82
    Opinion distributions and mean shadow ban strength versus time under shadow banning control policies for different objectives on a stochastic block model network.

    Opinion distributions and mean shadow ban strength versus time under shadow banning control policies for different objectives on a stochastic block model network. by Yen-Shao Chen (18264587)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  3. 83
    Decreased presence of tubulin-GFP at axonal MTs in a pulse chase experiment suggests changes in MT replenishment with age.

    Decreased presence of tubulin-GFP at axonal MTs in a pulse chase experiment suggests changes in MT replenishment with age. by Pilar Okenve-Ramos (18150546)

    Published 2024
    Save to List
    Saved in:
  4. 84
    Phase 1 pre- and post-test Means (<i>M</i>), Standard Deviations (<i>SD</i>), between group effect sizes (<i>d</i>), and RMANOVA results (<i>F</i>-value, <i>p</i>-value) for intervention and control groups.

    Phase 1 pre- and post-test Means (<i>M</i>), Standard Deviations (<i>SD</i>), between group effect sizes (<i>d</i>), and RMANOVA results (<i>F</i>-value, <i>p</i>-value) for interv... by Wendy C. Crone (2262169)

    Published 2023
    Save to List
    Saved in:
  5. 85
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 86
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Tixagevimab/ Cilgavimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Tixagevimab/ Cilgavimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 87
    Simulation of the average densities/concentrations of the variables for model (2)–(21) with ENZ, Sip-T, anti-PD-1 (<i>A</i><sub>1</sub>) and anti-CTLA-4 (<i>A</i><sub>4</sub>).

    Simulation of the average densities/concentrations of the variables for model (2)–(21) with ENZ, Sip-T, anti-PD-1 (<i>A</i><sub>1</sub>) and anti-CTLA-4 (<i>A</i><sub>4</sub>). by Nourridine Siewe (5081834)

    Published 2022
    Save to List
    Saved in:
  8. 88
    Simulation of the average densities/concentrations of the variables for model (2)–(21) with/without ENZ (ADT) at <i>γ</i><sub><i>E</i></sub> = 10<sup>−7</sup> g/cm<sup>3</sup>⋅d.

    Simulation of the average densities/concentrations of the variables for model (2)–(21) with/without ENZ (ADT) at <i>γ</i><sub><i>E</i></sub> = 10<sup>−7</sup> g/cm<sup>3</sup>⋅d.... by Nourridine Siewe (5081834)

    Published 2022
    Save to List
    Saved in:
  9. 89
    Percentage of exhale flux penetrating through the mask fabric for different values of <i>c</i><sub><i>k</i></sub>; a–c and d–f decreasing porosity for outward and inward protection model respectively; <i>k</i><sub><i>L</i></sub> is head loss coefficient for inward protection model.

    Percentage of exhale flux penetrating through the mask fabric for different values of <i>c</i><sub><i>k</i></sub>; a–c and d–f decreasing porosity for outward and inward protection... by Akshay Anand (118579)

    Published 2025
    Save to List
    Saved in:
  10. 90
    Antibody and antigen responses after treatment with nMAb vs placebo, day 1-90 (pooled nMAb treatments).

    Antibody and antigen responses after treatment with nMAb vs placebo, day 1-90 (pooled nMAb treatments). by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 91
    Quantitative antibody and antigen responses to nMAb vs placebo day 1-90: Pooled analysis of neutralizing monoclonal antibodies.

    Quantitative antibody and antigen responses to nMAb vs placebo day 1-90: Pooled analysis of neutralizing monoclonal antibodies. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 92
    The rate the bias decreases with sample duration is higher for cells with higher activity levels.

    The rate the bias decreases with sample duration is higher for cells with higher activity levels. by Liron Sheintuch (12078310)

    Published 2022
    Save to List
    Saved in:
  13. 93
    Large <i>Bgl-</i>FaNaC neurons labeled with HCR <i>in situ</i> hybridization.

    Large <i>Bgl-</i>FaNaC neurons labeled with HCR <i>in situ</i> hybridization. by Laura C. Vicente-Rodríguez (16437803)

    Published 2023
    Save to List
    Saved in:
  14. 94
    Phase 2 pre- and post-test Means (<i>M</i>), Standard Deviations (<i>SD</i>), between group effect sizes (<i>d</i>), and RMANOVA results (<i>F</i>-value, <i>p</i>-value) for intervention and control groups (Year 1 and Year 2 combined).

    Phase 2 pre- and post-test Means (<i>M</i>), Standard Deviations (<i>SD</i>), between group effect sizes (<i>d</i>), and RMANOVA results (<i>F</i>-value, <i>p</i>-value) for interv... by Wendy C. Crone (2262169)

    Published 2023
    Save to List
    Saved in:
  15. 95
    Evaluation of gallbladder fossa after liver removal.

    Evaluation of gallbladder fossa after liver removal. by Diana C. J. Rhodes (4268470)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  16. 96
    Plots gallbladder fossae volumes versus different dimensions of the fossa mold for livers with (blue) and without (red) gallbladders (males (squares), females (circles)), showing Pearson’s correlation coefficient (r) for each comparison.

    Plots gallbladder fossae volumes versus different dimensions of the fossa mold for livers with (blue) and without (red) gallbladders (males (squares), females (circles)), showing P... by Diana C. J. Rhodes (4268470)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  17. 97
    Box plots showing baseline prevalence and mean egg count at pre-MDA1 in districts that were responders compared to those that were persistent hotspots of decreasing praziquantel efficacy (EPHS).

    Box plots showing baseline prevalence and mean egg count at pre-MDA1 in districts that were responders compared to those that were persistent hotspots of decreasing praziquantel ef... by Takafira Mduluza (39754)

    Published 2025
    Save to List
    Saved in:
  18. 98
    Gallbladder fossa parameters in livers with gallbladders, segregated by sex.

    Gallbladder fossa parameters in livers with gallbladders, segregated by sex. by Diana C. J. Rhodes (4268470)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  19. 99
    Comparison of gallbladder fossa parameters in livers from female cadavers with and without gallbladders.

    Comparison of gallbladder fossa parameters in livers from female cadavers with and without gallbladders. by Diana C. J. Rhodes (4268470)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  20. 100
    Comparison of liver weights (raw and corrected for femur length) in cadavers with and without gallbladders.

    Comparison of liver weights (raw and corrected for femur length) in cadavers with and without gallbladders. by Diana C. J. Rhodes (4268470)

    Published 2021
    Subjects:
    Save to List
    Saved in:

Search Tools: